Appendix cancer rising among younger adults, U.S. study shows; Australian oncologist reports similar trend

A recent U.S. study has documented a marked increase in appendix cancer cases, particularly among people born after the 1970s, and found that about one in three diagnoses now occurs in adults younger than 50. The rise has prompted clinicians and researchers to call for more investigation into causes, earlier detection and improved awareness of the disease.

Appendiceal tumours were formerly considered rare and were most often identified in older adults. The new analysis, which examined incidence patterns in a U.S. population, indicated that gastrointestinal cancers overall are increasing at the fastest rate among all cancer types, and that appendiceal cancer is the fastest rising cancer affecting people under 50.

Associate Professor Kate Mahon, director of medical oncology at Chris O'Brien Lifehouse at Royal Prince Alfred Hospital in Sydney and a specialist in appendiceal cancer, said the findings reflect trends she has observed in Australia. "This new study has shown that out of all cancers, the rates of gastrointestinal cancers are going up fastest," she said. "And in cancers affecting people under 50, appendix cancer is the fastest rising."

The study cohort was U.S.-based, and authors reported the shift toward younger age at diagnosis after stratifying cases by year of birth. Researchers described the pattern as notable because appendiceal tumours had traditionally been diagnosed later in life and were often discovered incidentally during surgery for other conditions.

Experts caution that the reasons for the increase remain unclear. Researchers and clinicians say multiple factors are being examined, including changes in diagnostic practices, increased use of imaging and surgical procedures, environmental exposures, lifestyle factors and the gut microbiome. At present, no single cause has been established.

Clinicians emphasize that appendiceal cancers represent a heterogeneous group of tumours. Pathologic types range from neuroendocrine tumours, which can be slow-growing, to mucinous neoplasms that can cause a condition known as pseudomyxoma peritonei when mucin spreads through the abdominal cavity. Presentation and prognosis vary by tumour type, stage at diagnosis and patient characteristics.

The shift toward younger patients has implications for clinical practice and public health. Earlier onset of cancer can affect treatment decisions, fertility planning and long-term survivorship needs. Oncologists say increased awareness among primary care clinicians and surgeons could lead to timelier referrals and appropriate imaging or specialist assessment when symptoms such as persistent abdominal pain, unexplained changes in bowel habits or unexplained abdominal distension occur.

Researchers who authored the U.S. analysis called for further epidemiologic and laboratory studies to clarify trends and identify modifiable risk factors. They also recommended improved registry data and standardized reporting to track incidence and outcomes more accurately over time.

Mahon said multidisciplinary collaboration will be important to respond to the changing epidemiology. "We need more research, and we need to make sure that younger patients with concerning symptoms are not dismissed because of their age," she said.

Public health authorities and cancer research organisations routinely review incidence data to detect shifts in disease patterns. As appendiceal cancer rises among younger cohorts in multiple countries, clinicians and investigators say coordinated efforts to improve detection, understand causes and expand research funding will be important to address the trend.